hrp0089p1-p259 | Thyroid P1 | ESPE2018

A Novel Mutation of IGSF1 Gene

Sotiridou Ellada , Schoenmakers Nadia , Datta Vipan

Introduction: Mutations in IGSF1 result in X-linked congenital central hypothyroidism, macroorchidism and a variable spectrum of anterior pituitary dysfunction, most commonly including hypoprolactinaemia. We identified a novel hemizygous IGSF1 mutation (c.3191T>C, p.L1064P) in a 17 year-old adolescent, inherited from his heterozygous mother.Case: A novel hemizygous IGSF1 mutation (c.3191T>C, p.L1064P) was identified by direct se...

hrp0092p2-143 | Fetal, Neonatal Endocrinology and Metabolism (to include Hypoglycaemia) | ESPE2019

Two Siblings with Tyrosinaemia Type 1 and Transient Hyperinsulinaemic Hypoglycaemia

Sotiridou Ellada , Aftab Sommayya , Dastamani Antonia , Doodson Louise , Batzios Spyros , Shah Pratik

Introduction: Tyrosinaemia type 1 (TT1) is a rare autosomal recessively inherited disorder of tyrosine metabolism leading to accumulation of tyrosine and its metabolites in liver, kidney and central nervous system. TT1 is a heterogeneous disorder with a broad spectrum of clinical manifestations. Hypoglycaemia is common, especially in the acute phase of the disease due to liver failure and reduced hepatic clearance of insulin. However, confirmed cases of hyperi...

hrp0092rfc9.5 | Fetal, Neonatal Endocrinology and Metabolism (to include Hypoglycaemia) | ESPE2019

Spectrum of Neuro-Developmental Disorders in Children with Congenital Hyperinsulinism Due to Activating Mutations in GLUD1

Aftab Sommayya , Gubaeva Diliara , Dastamani Antonia , Sotiridou Ellada , Gilbert Clare , Houghton Jayne , Flanagan Sarah E. , Melikyan Maria , Shah Pratik

Background & Objective: Hyperinsulinism-Hyperammonaemia (HI/HA) syndrome is the second most common type of congenital hyperinsulinism (CHI) in outbred populations. HI/HA is caused by an activating mutation in the GLUD1 gene which encodes the intra-mitochondrial enzyme glutamate dehydrogenase (GDH).The aim of this study was to determine the clinical presentation, treatment and risk factors of neuro-developmental disorders in ...

hrp0097p1-243 | Diabetes and Insulin | ESPE2023

A comparison of Quality of Life in Children with Diabetes Type 1 in Cyprus treated with Multiple daily injections of insulin to children utilizing CGM as adjutant to MDI and to children treated with Continuous Subcutaneous Insulin Infusion.

Sotiriou Elena , Skordis Nicos

Background: Insulin remains the mainstay treatment for diabetes type 1(T1D), more recently several technological advances have been introduced to assist with the treatment. Continuous Subcutaneous insulin infusion (CSII) devices and continues glycose monitors (CGM) have gained a lot of popularity and are thought to help patients achieve better glycaemic control. HbA1c levels can be used to assess glycaemic control. There are conflicting reports on whether thos...

hrp0097p1-38 | Diabetes and Insulin | ESPE2023

Efficacy of faster aspart in insulin pumps in children and adolescents with Type 1 Diabetes Mellitus: A single-center study with real-world data

Sotiriou Georgia , Christelia Katerina , Stamati Athina , Dimitriadou Meropi , Christoforidis Athanasios

Aim: To assess the efficacy of faster aspart (FIAsp) in paediatric population with type 1 diabetes mellitus (T1DM) and insulin pumps in real-world settings.Methods: We conducted a prospective analysis of 16 children and adolescents with T1DM on insulin pump that switched from Aspart to FIAsp from September 2019 to June 2020. We performed within groups and between groups analyses in three time points: 3 months before FIAs...

hrp0097p2-188 | Adrenals and HPA Axis | ESPE2023

7-year-old girl as compound heterozygote of non-classic congenital adrenal hyperplasia

Bali Maria , Sotiriou Spyridoula , Magoula Marousa , Kalamara Panagiota , Papafotiou Chrysanthe , Papagiannidi Marina , Ioannidou Gerina

Background: Deficiency of 21-hydroxylase (CYP21A2) is responsible of 90-95% of all cases of congenital adrenal hyperplasia (CAH). CYP21A2 converts 17OHprogesterone into 11deoxycortisol and is encoded by the CYP21A2 gene on chromosome 6p21.3, within the class III region of the highly polymorphic HLA histocompatibility complex. CAH refers to a group of autosomal recessive disorders. Nonclassic CAH (NCAH) is milder and more common, however it may not be identifie...

hrp0097p2-216 | Adrenals and HPA Axis | ESPE2023

Non classic congenital adrenal hyperplasia caused by mutations in CYP21A2

Magoula Marousa , Sotiriou Spyridoula , Bali Maria , Kalamara Panagiota , Papafotiou Chrysanthe , Papagiannidi Marina , Ioannidou Gerina

Background: Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive genetic defects in cortisol synthesis caused by the deficiency of 21-hydroxylase which convert 17-hydroxyprogesterone to 11-deoxycortisol. A variety of mutations in one or more genes encoding enzymes essential for cortisol synthesis leads to a spectrum of disorders and disease severity. In general, complete or nearly complete enzymatic defects result in overt adrenal insufficien...

hrp0097p2-139 | Adrenals and HPA Axis | ESPE2023

A 6-year-old boy with Duchenne Muscular Dystrophy and acute adrenal insufficiency: a case report

Magoula Marousa , Ioannidou Gerina , Sotiriou Spyridoula , Vasilakis Ioannis-Anargyros , Mpali Maria , Kalamata Panagiota , Athanasopoulou Evianna , Papafotiou Chrysanthe

Background: Adrenal crisis is a life-threatening condition caused by either primary adrenal insufficiencyor hypothalamic-pituitary-adrenal (HPA) axis dysfunction, commonly due to chronic use of high-dose glucocorticoids. Clinical presentation, often with gastrointestinal symptoms (weakness, nausea, vomiting, epigastric pain) poses clinical challenges, sometimes leading to an incorrect diagnosis of gastroenteritis.Material:</stron...

hrp0089p3-p127 | Fat, Metabolism and Obesity P3 | ESPE2018

BigO: Big Data Against Childhood Obesity

Diou Christos , Ioakeimidis Ioannis , Charmandari Evangelia , Kassari Penio , Lekka Irini , Mars Monica , Bergh Cecilia , Kechadi Tahar , Doyle Gerardine , O'Malley Grace , Heimeier Rachel , Lindroos Anna Karin , Sotiriou Sofoklis , Koukoula Evangelia , Guillen Sergio , Lymperopoulos George , Maglaveras Nicos , Delopoulos Anastasios

Background: Childhood obesity is a major global and European public health problem. The need for community-targeted actions has long been recognized, however it has been prevented by the lack of monitoring and evaluation framework, and the methodological inability to objectively quantify the local community characteristics in a reasonable timeframe. Recent technological achievements in mobile and wearable electronics and Big Data infrastructures allow the engagement of Europea...